Duke launches study to find alternative treatments for mild-to-moderate COVID-19
A study led by the Duke Clinical Research Institute has expanded its testing platform to evaluate three repurposed medications in the search for effective, safe treatments for mild-to-moderate COVID-19. Repurposed medications are those already approved by the U.S. Food and Drug Administration for other indications.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed